Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 616 AL 630

Food-derived bioactive peptides with neuroprotective properties: a narrative review

Wang Z, Zhao Y, Li D.

Nutr Res. 2026 Oct;154:89-113. doi: 10.1016/j.nutres.2026.08.004. Epub 2026 Aug 24.

Artificial Intelligence and Digital Biomarkers for Early Detection and Monitoring of Neurological Disorders: A Narrative Review

Rahmani AH, Sarwar T.

Diagnostics (Basel). 2026 Aug 31;16(17):2799. doi: 10.3390/diagnostics16172799.

Alkaloids as Emerging Neuroprotective Agents for Neurodegenerative Disorders: Insights into Tryptanthrin and Its Derivatives

Khan A, Khan H, Park IH, Aldahmash BA, Khan MS, Yang G, Kang KS.

Int J Mol Sci. 2026 Aug 20;27(16):7436. doi: 10.3390/ijms27167436.

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report)

Hou L, Ma X, Wang C, Ji L, Peng P.

Front Psychiatry. 2026 Sep 11;17:1935514. doi: 10.3389/fpsyt.2026.1935514. eCollection 2026.

From metabolism to neurodegeneration: how microglial functional reprogramming drives neurodegenerative diseases

Cui Q, Zheng K, Liu Q, Wang L, Liu Y, Bai R, Zhang W, Guo J, Chang X, Wang J.

Front Mol Neurosci. 2026 Aug 20;19:1921079. doi: 10.3389/fnmol.2026.1921079. eCollection 2026.

Repurposing antimicrobial agents for neuroprotection: Mechanisms, clinical potential, and challenges

Manavi MA, Salehi M, Mohammad Jafari R, Goudarzi R, Khosravi S, Dehpour AR.

Neuroprotection. 2026 Sep 11:10.1002/nep3.70042. doi: 10.1002/nep3.70042. Online ahead of print.

[Molecular Imaging of Tau and α-Synuclein Pathologies: Technical Advances, Challenges, and Opportunities]

Gnörich JS, Franzmeier N, Brendel M.

Fortschr Neurol Psychiatr. 2026 Sep;94(9):371-376. doi: 10.1055/a-2823-2465. Epub 2026 Mar 27.

Motor System Neurodegeneration in Aging and Synucleinopathies: Circuit Vulnerability and Neuroimaging Biomarkers

Wen J, Xu X, Ge Y.

Aging Dis. 2026 Aug 25. doi: 10.14336/AD.2026.0457. Online ahead of print.

Gut Microbial Metabolism as a Dynamic Interface in Neurodegenerative Diseases

Kang Z, Meng R, Nie M, Wang T.

Metabolites. 2026 Sep 2;16(9):642. doi: 10.3390/metabo16090642.

A Review of the Therapeutic Potential of Stem Cell-Derived Nanocarriers to Treat Neurological Disorders

Okafor NI, Abdelgader A, Abobaker M, Choonara YE.

ChemistryOpen. 2026 Sep;15(9):e202500425. doi: 10.1002/open.202500425.

How Gut Microbiota Influence Healthy Aging: Overview of Reviews

Todmal TG, Bibi R, Cangelosi G, Panella M, Masini A.

Geriatrics (Basel). 2026 Aug 17;11(4):107. doi: 10.3390/geriatrics11040107.

Ultraviolet radiation and neurodegeneration: molecular mechanisms underlying dual neuroprotective and neurotoxic effects

Praharaj S, Chakraborty E, Mahalingam G.

Front Cell Neurosci. 2026 Aug 13;20:1909393. doi: 10.3389/fncel.2026.1909393. eCollection 2026.

Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives

Gapińska N, Abram M, Jakubiec M, Rafało-Ulińska A, Szewczyk B, Kamiński K, Wlaź P, Socała K.

Pharmacol Ther. 2026 Aug 29;288:109106. doi: 10.1016/j.pharmthera.2026.109106. Online ahead of print.

From Mouth to Mind: Unraveling the Oral Microbiome's Role in Orofacial Pain and Neurodegeneration

Moses S, Phulambrikar T, Dosi T.

J Clin Pract Res. 2026 Jul 20;48(4):356-367. doi: 10.14744/cpr.2026.15313. eCollection 2026 Aug.

Update on novel, validly published, and included bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2025

Carella A, Carroll KC, Munson E.

J Clin Microbiol. 2026 Oct 14;64(10):e0097326. doi: 10.1128/jcm.00973-26. Epub 2026 Sep 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias